Alpha DNA Investment Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,016
Closed -$464K 203
2024
Q3
$464K Buy
+10,016
New +$464K 0.17% 134